Please use this identifier to cite or link to this item:
https://doi.org/10.1080/10428194.2017.1298755
| Title: | Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup | Authors: | Heinz Ludwig Meletios A. Dimopoulos Philippe Moreau Wee Joo Chng Hartmut Goldschmidt Roman Hajek Thierry Facon Ludek Pour Ruben Niesvizky Albert Oriol Laura Rosinol Aleksandr Suvorov Gianluca Gaidano Tomas Pika Katja Weisel Vesselina Goranova-Marinova Antonio Palumbo Heidi Gillenwater Nehal Mohamed Sanjay Aggarwal Shibao Feng Douglas Joshua |
Issue Date: | 17-Mar-2017 | Publisher: | Taylor & Francis | Citation: | Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee Joo Chng, Hartmut Goldschmidt, Roman Hajek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosinol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng, Douglas Joshua (2017-03-17). Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup. Leukemia & Lymphoma 58 (10) : 2501-2504. ScholarBank@NUS Repository. https://doi.org/10.1080/10428194.2017.1298755 | Source Title: | Leukemia & Lymphoma | URI: | http://scholarbank.nus.edu.sg/handle/10635/141100 | ISSN: | 1042-8194 | DOI: | 10.1080/10428194.2017.1298755 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10.108010428194.2017.1298755.zip | 467.36 kB | ZIP | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.